209 related articles for article (PubMed ID: 19740262)
1. Acidosis and raised norepinephrine levels are associated with exercise dyspnoea in idiopathic pulmonary fibrosis.
Miki K; Maekura R; Hiraga T; Hashimoto H; Kitada S; Miki M; Yoshimura K; Tateishi Y; Fushitani K; Motone M
Respirology; 2009 Sep; 14(7):1020-6. PubMed ID: 19740262
[TBL] [Abstract][Full Text] [Related]
2. Exertional dyspnea-related acidotic and sympathetic responses in patients with sequelae of pulmonary tuberculosis.
Miki K; Maekura R; Hiraga T; Hashimoto H; Kitada S; Miki M; Yoshimura K; Tateishi Y; Sugano T; Motone M
J Physiol Sci; 2010 May; 60(3):187-93. PubMed ID: 20087706
[TBL] [Abstract][Full Text] [Related]
3. Effects of oxygen on exertional dyspnoea and exercise performance in patients with chronic obstructive pulmonary disease.
Miki K; Maekura R; Hiraga T; Kitada S; Miki M; Yoshimura K; Tateishi Y
Respirology; 2012 Jan; 17(1):149-54. PubMed ID: 22008208
[TBL] [Abstract][Full Text] [Related]
4. Exertional acidotic responses in idiopathic pulmonary fibrosis: the mechanisms of exertional dyspnea.
Miki K; Maekura R; Miki M; Kitada S; Yoshimura K; Tateishi Y; Mori M
Respir Physiol Neurobiol; 2013 Feb; 185(3):653-8. PubMed ID: 23246672
[TBL] [Abstract][Full Text] [Related]
5. Dyspnoea at 6-min walk test in idiopathic pulmonary fibrosis: comparison with COPD.
Nishiyama O; Taniguchi H; Kondoh Y; Kimura T; Kato K; Ogawa T; Watanabe F; Arizono S
Respir Med; 2007 Apr; 101(4):833-8. PubMed ID: 16962758
[TBL] [Abstract][Full Text] [Related]
6. Effects of sympathetic inhibition on exertional dyspnoea, ventilatory and metabolic responses to exercise in normotensive humans.
Galloway SD; De Vito G; McClure S; Nimmo MA; McMurray JJ
Clin Sci (Lond); 2000 Sep; 99(3):223-30. PubMed ID: 11787475
[TBL] [Abstract][Full Text] [Related]
7. Effects of proportional assisted ventilation on exercise performance in idiopathic pulmonary fibrosis patients.
Moderno EV; Yamaguti WP; Schettino GP; Kairalla RA; Martins MA; Carvalho CR; Carvalho CR
Respir Med; 2010 Jan; 104(1):134-41. PubMed ID: 19716690
[TBL] [Abstract][Full Text] [Related]
8. Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis.
Nishiyama O; Kondoh Y; Kimura T; Kato K; Kataoka K; Ogawa T; Watanabe F; Arizono S; Nishimura K; Taniguchi H
Respirology; 2008 May; 13(3):394-9. PubMed ID: 18399862
[TBL] [Abstract][Full Text] [Related]
9. Effect of disability level on response to pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis.
Kozu R; Jenkins S; Senjyu H
Respirology; 2011 Nov; 16(8):1196-202. PubMed ID: 21810145
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
[TBL] [Abstract][Full Text] [Related]
11. Role of hyperinflation vs. deflation on dyspnoea in severely to extremely obese subjects.
Romagnoli I; Laveneziana P; Clini EM; Palange P; Valli G; de Blasio F; Gigliotti F; Scano G
Acta Physiol (Oxf); 2008 Aug; 193(4):393-402. PubMed ID: 18363899
[TBL] [Abstract][Full Text] [Related]
12. The 15-step oximetry test: a reliable tool to identify candidates for lung transplantation among patients with idiopathic pulmonary fibrosis.
Shitrit D; Rusanov V; Peled N; Amital A; Fuks L; Kramer MR
J Heart Lung Transplant; 2009 Apr; 28(4):328-33. PubMed ID: 19332258
[TBL] [Abstract][Full Text] [Related]
13. MRC chronic Dyspnea Scale: Relationships with cardiopulmonary exercise testing and 6-minute walk test in idiopathic pulmonary fibrosis patients: a prospective study.
Manali ED; Lyberopoulos P; Triantafillidou C; Kolilekas LF; Sotiropoulou C; Milic-Emili J; Roussos C; Papiris SA
BMC Pulm Med; 2010 May; 10():32. PubMed ID: 20509928
[TBL] [Abstract][Full Text] [Related]
14. Effect of ambulatory oxygen on exertional dyspnea in IPF patients without resting hypoxemia.
Nishiyama O; Miyajima H; Fukai Y; Yamazaki R; Satoh R; Yamagata T; Sano H; Iwanaga T; Higashimoto Y; Nakajima H; Kume H; Tohda Y
Respir Med; 2013 Aug; 107(8):1241-6. PubMed ID: 23806287
[TBL] [Abstract][Full Text] [Related]
15. Predictors of benefit following pulmonary rehabilitation for interstitial lung disease.
Holland AE; Hill CJ; Glaspole I; Goh N; McDonald CF
Respir Med; 2012 Mar; 106(3):429-35. PubMed ID: 22182340
[TBL] [Abstract][Full Text] [Related]
16. Sleep quality and associated daytime consequences in patients with idiopathic pulmonary fibrosis.
Mermigkis C; Stagaki E; Amfilochiou A; Polychronopoulos V; Korkonikitas P; Mermigkis D; Bregou M; Kouris N; Bouros D
Med Princ Pract; 2009; 18(1):10-5. PubMed ID: 19060484
[TBL] [Abstract][Full Text] [Related]
17. Exercise decreases plasma antioxidant capacity and increases urinary isoprostanes of IPF patients.
Jackson R; Ramos C; Gupta C; Gomez-Marin O
Respir Med; 2010 Dec; 104(12):1919-28. PubMed ID: 20739168
[TBL] [Abstract][Full Text] [Related]
18. Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease.
Holland AE; Hill CJ; Conron M; Munro P; McDonald CF
Thorax; 2008 Jun; 63(6):549-54. PubMed ID: 18245143
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of health-related quality-of-life and dyspnea scales in patients with idiopathic pulmonary fibrosis. Correlation with pulmonary function tests.
Tzanakis N; Samiou M; Lambiri I; Antoniou K; Siafakas N; Bouros D
Eur J Intern Med; 2005 Apr; 16(2):105-112. PubMed ID: 15833676
[TBL] [Abstract][Full Text] [Related]
20. The Medical Research Council dyspnea scale in the estimation of disease severity in idiopathic pulmonary fibrosis.
Papiris SA; Daniil ZD; Malagari K; Kapotsis GE; Sotiropoulou C; Milic-Emili J; Roussos C
Respir Med; 2005 Jun; 99(6):755-61. PubMed ID: 15878493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
